JNBA Financial Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $91.2K | Sell |
422
-174
| -29% | -$33.3K | 0.01% | 255 |
|
|
2026
Q1 | $109K | Hold |
596
| – | – | 0.01% | 227 |
|
|
2025
Q4 | $105K | Sell |
596
-30
| -5% | -$4.9K | 0.01% | 235 |
|
|
2025
Q3 | $87.7K | Hold |
626
| – | – | 0.01% | 246 |
|
|
2025
Q2 | $78.6K | Hold |
626
| – | – | 0.01% | 249 |
|
|
2025
Q1 | $85.7K | Sell |
626
-240
| -28% | -$34.3K | 0.01% | 230 |
|
|
2024
Q4 | $132K | Sell |
866
-150
| -15% | -$25.3K | 0.01% | 194 |
|
|
2024
Q3 | $197K | Sell |
1,016
-55
| -5% | -$11.5K | 0.02% | 184 |
|
|
2024
Q2 | $248K | Hold |
1,071
| – | – | 0.03% | 173 |
|
|
2024
Q1 | $231K | Sell |
1,071
-201
| -16% | -$47.1K | 0.02% | 180 |
|
|
2023
Q4 | $329K | Hold |
1,272
| – | – | 0.04% | 162 |
|
|
2023
Q3 | $327K | Buy |
1,272
+191
| +18% | +$51.1K | 0.04% | 158 |
|
|
2023
Q2 | $308K | Sell |
1,081
-5
| -0.5% | -$1.49K | 0.04% | 166 |
|
|
2023
Q1 | $302K | Hold |
1,086
| – | – | 0.04% | 165 |
|
|
2022
Q4 | $301K | Hold |
1,086
| – | – | 0.04% | 158 |
|
|
2022
Q3 | $290K | Hold |
1,086
| – | – | 0.04% | 158 |
|
|
2022
Q2 | $221K | Sell |
1,086
-135
| -11% | -$27.6K | 0.03% | 172 |
|
|
2022
Q1 | $257K | Sell |
1,221
-25
| -2% | -$5.44K | 0.03% | 171 |
|
|
2021
Q4 | $299K | Sell |
1,246
-5
| -0.4% | -$1.29K | 0.04% | 167 |
|
|
2021
Q3 | $354K | Hold |
1,251
| – | – | 0.05% | 149 |
|
|
2021
Q2 | $433K | Sell |
1,251
-185
| -13% | -$56K | 0.06% | 132 |
|
|
2021
Q1 | $402K | Hold |
1,436
| – | – | 0.06% | 133 |
|
|
2020
Q4 | $352K | Sell |
1,436
-65
| -4% | -$16.8K | 0.06% | 131 |
|
|
2020
Q3 | $426K | Hold |
1,501
| – | – | 0.09% | 102 |
|
|
2020
Q2 | $402K | Sell |
1,501
-75
| -5% | -$22.5K | 0.09% | 106 |
|
|
2020
Q1 | $499K | Sell |
1,576
-10
| -0.6% | -$3.04K | 0.12% | 88 |
|
|
2019
Q4 | $471K | Hold |
1,586
| – | – | 0.09% | 102 |
|
|
2019
Q3 | $369K | Sell |
1,586
-159
| -9% | -$37K | 0.08% | 107 |
|
|
2019
Q2 | $408K | Buy |
1,745
+440
| +34% | +$102K | 0.08% | 106 |
|
|
2019
Q1 | $308K | Sell |
1,305
-25
| -2% | -$7.87K | 0.07% | 115 |
|
|
2018
Q4 | $400K | Buy |
1,330
+905
| +213% | +$289K | 0.09% | 96 |
|
|
2018
Q3 | $150K | Sell |
425
-1,030
| -71% | -$355K | 0.07% | 148 |
|
|
2018
Q2 | $422K | Hold |
1,455
| – | – | 0.09% | 94 |
|
|
2018
Q1 | $398K | Sell |
1,455
-25
| -2% | -$7.76K | 0.09% | 92 |
|
|
2017
Q4 | $471K | Sell |
1,480
-15
| -1% | -$4.81K | 0.1% | 85 |
|
|
2017
Q3 | $468K | Hold |
1,495
| – | – | 0.1% | 77 |
|
|
2017
Q2 | $406K | Buy |
1,495
+30
| +2% | +$7.93K | 0.09% | 81 |
|
|
2017
Q1 | $401K | Buy |
1,465
+14
| +1% | +$3.96K | 0.09% | 80 |
|
|
2016
Q4 | $411K | Buy |
1,451
+486
| +50% | +$144K | 0.1% | 77 |
|
|
2016
Q3 | $302K | Sell |
965
-456
| -32% | -$135K | 0.04% | 162 |
|
|
2016
Q2 | $344K | Buy |
1,421
+405
| +40% | +$107K | 0.1% | 78 |
|
|
2016
Q1 | $264K | Buy |
1,016
+85
| +9% | +$22.5K | 0.1% | 85 |
|
|
2015
Q4 | $285K | Buy |
931
+195
| +26% | +$56K | 0.11% | 83 |
|
|
2015
Q3 | $215K | Buy |
736
+700
| +1,944% | +$231K | 0.09% | 91 |
|
|
2015
Q2 | $15K | Hold |
36
| – | – | 0.01% | 312 |
|
|
2015
Q1 | $15K | Hold |
36
| – | – | 0.01% | 324 |
|
|
2014
Q4 | $12K | Hold |
36
| – | – | ﹤0.01% | 340 |
|
|
2014
Q3 | $12K | Buy |
+36
| New | +$11.9K | 0.01% | 350 |
|
Other funds holding BIIB
AIM
AAMU
ADEF
BPC
HP
JNBA Financial Advisors's BIIB Position: Q2 2026 in Review
JNBA Financial Advisors reduced its Biogen (BIIB) stake by 29% in Q2 2026, selling an estimated $33.3K and leaving 422 shares worth $91.2K. The position accounts for 0.01% of the portfolio, ranked #255.
JNBA Financial Advisors first reported a position in BIIB in Q3 2014 and has held it in 48 quarters since. The position peaked at $499K in Q1 2020. 301 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- JNBA Financial Advisors held 422 shares of Biogen worth $91.2K as of Q2 2026.
- JNBA Financial Advisors sold 174 Biogen shares in Q2 2026, an estimated $33.3K.
- Biogen made up 0.01% of JNBA Financial Advisors's portfolio in Q2 2026, its #255 holding.
- JNBA Financial Advisors first reported a position in Biogen in Q3 2014 and has held it in 48 quarters since.
- JNBA Financial Advisors's Biogen position peaked at $499K in Q1 2020.
- 301 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on JNBA Financial Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.